Symbol="KTRA"
AssetType="Common Stock"
Name="Kintara Therapeutics Inc"
Description="Kintara Therapeutics, Inc., a clinical-stage drug development company, focuses on developing and commercializing cancer therapies to treat cancer patients. The company is headquartered in San Diego, California."
CIK="1498382"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="SPECIALTY CLEANING, POLISHING AND SANITATION PREPARATIONS"
Address="722 B KINGSTON ROAD, TORONTO, ON, CA"
FiscalYearEnd="June"
LatestQuarter="2023-03-31"
MarketCapitalization="8714700"
EBITDA="-16845000"
PERatio="None"
PEGRatio="None"
BookValue="-4.054"
DividendPerShare="0"
DividendYield="0"
EPS="-19.05"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-1.082"
ReturnOnEquityTTM="-2.545"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-19.05"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="150"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="7.81"
EVToRevenue="-"
EVToEBITDA="-0.82"
Beta="1.03"
num_52WeekHigh="15.5"
num_52WeekLow="2.7"
num_50DayMovingAverage="3.33"
num_200DayMovingAverage="5.11"
SharesOutstanding="1692200"
DividendDate="2019-05-08"
ExDividendDate="None"
symbol="KTRA"
open="5.15"
high="5.20"
low="4.84"
price="5.00"
volume="64818.00"
latest_trading_day="2023-07-07"
previous_close="5.21"
change="-0.21"
change_percent="-4.0307%"
aroon_positive_momentum_days="46"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="46"
Volume_recent_avg="124722"
Change_recent_avg="0.01"
Delta_recent_avg="0.39"
Variance_recent_avg="0.2"
Change_ratio_recent_avg="-0.46"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="46"
Aroon_momentum_negative="54"
image_negative_thumbnail_id_1="514"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0091.jpeg"
image_negative_thumbnail_id_2="152"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0024.jpeg"
image_neutral_thumbnail_id_1="552"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_neutral_thumbnail_id_2="539"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0060.jpeg"
image_positive_thumbnail_id_1="1011"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0173.jpeg"
image_positive_thumbnail_id_2="990"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0152.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
